ArticleCureus2023

Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping Mutation.

Naohiro Nitta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.